David Enoch

5.4k total citations
94 papers, 2.8k citations indexed

About

David Enoch is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, David Enoch has authored 94 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 43 papers in Epidemiology and 22 papers in Clinical Biochemistry. Recurrent topics in David Enoch's work include Bacterial Identification and Susceptibility Testing (22 papers), Antifungal resistance and susceptibility (19 papers) and Fungal Infections and Studies (15 papers). David Enoch is often cited by papers focused on Bacterial Identification and Susceptibility Testing (22 papers), Antifungal resistance and susceptibility (19 papers) and Fungal Infections and Studies (15 papers). David Enoch collaborates with scholars based in United Kingdom, United States and Germany. David Enoch's co-authors include Nicholas M. Brown, Sani H. Aliyu, H. Ludlam, J.A. Karas, Christianne Micallef, R E Warren, Sani Aliyu, Jonathan A. Otter, A.P.R. Wilson and Cliodna McNulty and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

David Enoch

92 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Enoch United Kingdom	26	1.4k	1.1k	465	337	301	94	2.8k
Stefano Di Bella Italy	25	921 0.7×	719 0.7×	453 1.0×	367 1.1×	177 0.6×	142	2.3k
Thomas Bischoff Switzerland	13	2.3k 1.7×	1.7k 1.6×	434 0.9×	538 1.6×	481 1.6×	47	4.0k
Tun‐Chieh Chen Taiwan	28	980 0.7×	660 0.6×	178 0.4×	257 0.8×	57 0.2×	125	2.2k
David B. Huang United States	31	1.5k 1.1×	613 0.6×	416 0.9×	529 1.6×	80 0.3×	129	3.3k
J. Kristie Johnson United States	41	2.4k 1.7×	1.5k 1.4×	2.2k 4.8×	938 2.8×	991 3.3×	181	5.6k
Michael Bell United States	25	1.2k 0.9×	1.1k 1.0×	351 0.8×	359 1.1×	133 0.4×	68	3.2k
Mark E. Jones United States	29	905 0.7×	1.8k 1.7×	985 2.1×	328 1.0×	308 1.0×	73	3.2k
John Williamson United States	23	558 0.4×	639 0.6×	153 0.3×	74 0.2×	262 0.9×	96	1.9k
Joaquím Gascón Spain	51	2.0k 1.4×	4.9k 4.6×	551 1.2×	709 2.1×	62 0.2×	290	9.2k
J. A. A. Hoogkamp‐Korstanje Netherlands	34	1.5k 1.1×	1.2k 1.1×	448 1.0×	413 1.2×	148 0.5×	111	3.4k

Countries citing papers authored by David Enoch

Since Specialization

Citations

This map shows the geographic impact of David Enoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Enoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Enoch more than expected).

Fields of papers citing papers by David Enoch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Enoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Enoch. The network helps show where David Enoch may publish in the future.

Co-authorship network of co-authors of David Enoch

This figure shows the co-authorship network connecting the top 25 collaborators of David Enoch. A scholar is included among the top collaborators of David Enoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Enoch. David Enoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Enoch, David, et al.. (2025). Anthropometric and metabolic differences and distribution of ABCG2 rs2231142 variant between lowland and highland Papuans in West Papua, Indonesia. Journal of PHYSIOLOGICAL ANTHROPOLOGY. 44(1). 14–14.

Neofytos, Dionysios, Antonio Pagliuca, Edward Broughton, et al.. (2024). Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019). Infectious Diseases and Therapy. 13(12). 2527–2543. 2 indexed citations

Micallef, Christianne, et al.. (2023). Using Behavior Change Theory to Identify Drivers and Barriers for Antifungal Treatment Decisions: A Case Study in a Large Teaching Hospital in the East of England, UK. Infectious Diseases and Therapy. 12(5). 1393–1414. 1 indexed citations

Wilson, Jennie, H Griffin, Alison Tingle, et al.. (2023). The role of pandemic planning in the management of COVID-19 in England from an infection prevention and control perspective: results of a national survey. Public Health. 217. 89–94. 4 indexed citations

Ramsay, Isobel, Katherine Sharrocks, Ben Warne, et al.. (2022). Investigation of healthcare-associated SARS-CoV-2 infection: Learning outcomes from an investigative process in the initial phase of the pandemic. Journal of Infection Prevention. 23(5). 197–205.

Micallef, Christianne, et al.. (2022). The role of hospital antimicrobial and infectious diseases pharmacists in the UK: a theoretically underpinned exploration. JAC-Antimicrobial Resistance. 5(1). dlac136–dlac136. 2 indexed citations

Goldenberg, Simon, Andrew Dodgson, Gavin Barlow, et al.. (2022). Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK). Advances in Therapy. 39(8). 3602–3615. 6 indexed citations

Kron, Anna, Santiago Grau, David Enoch, et al.. (2021). Reimbursement of innovative pharmaceuticals in English and Spanish hospitals—The example of isavuconazole. Mycoses. 64(10). 1213–1222. 2 indexed citations

Enoch, David. (2018). Against Utopianism: Noncompliance and Multiple Agents. The Journal of the Abraham Lincoln Association. 18(16). 13 indexed citations

10.

Ramsay, Isobel, Nicholas M. Brown, & David Enoch. (2018). Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection. SHILAP Revista de lepidopterología. 11. 203455111–203455111. 8 indexed citations

11.

Enoch, David. (2017). Political Philosophy and Epistemology. Oxford University Press eBooks. 4 indexed citations

12.

Wilson, A.P.R., David M. Livermore, Jonathan A. Otter, et al.. (2015). Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. Journal of Hospital Infection. 92. S1–S44. 94 indexed citations

13.

Graaf, Hans de, et al.. (2015). Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. European Journal of Clinical Microbiology & Infectious Diseases. 34(7). 1281–1287. 26 indexed citations

14.

Enoch, David, et al.. (2013). Abdominal tuberculosis: a retrospective review of cases presenting to a UK district hospital. QJM. 106(4). 347–354. 28 indexed citations

15.

Enoch, David, et al.. (2010). Outcome for Gram-negative bacteraemia when following restrictive empirical antibiotic guidelines. QJM. 104(5). 411–419. 15 indexed citations

16.

Mok, Hoi Ping, David Enoch, & Olajumoke Sule. (2009). Emphysematous cystitis in an 80-year-old female. International Journal of Infectious Diseases. 14(4). e361–e362. 1 indexed citations

17.

Ludlam, H. & David Enoch. (2008). Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?. International Journal of Antimicrobial Agents. 32(2). 101–105. 8 indexed citations

18.

Enoch, David, et al.. (2007). A troublesome head-butt. The Lancet Infectious Diseases. 7(10). 694–694. 2 indexed citations

19.

Karas, J.A., et al.. (2006). Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. Journal of Hospital Infection. 62(4). 480–486. 18 indexed citations

20.

Enoch, David. (1994). Patient or Pretender: Inside the Strange World of Factitious Disorders. BMJ. 308(6937). 1174.2–1175. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact